Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents (QoQ) (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Arcturus Therapeutics Holdings 165.13 Mn -46.25 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.46%
Dec 31, 2025 28.03%
Sep 30, 2025 -8.20%
Jun 30, 2025 -9.44%
Mar 31, 2025 -26.19%
Dec 31, 2024 23.92%
Sep 30, 2024 -8.89%
Jun 30, 2024 -9.73%
Mar 31, 2024 -1.24%
Dec 31, 2023 -6.38%
Sep 30, 2023 -3.57%
Jun 30, 2023 -1.36%
Mar 31, 2023 -16.32%
Dec 31, 2022 64.88%
Sep 30, 2022 -16.16%
Jun 30, 2022 -11.32%
Mar 31, 2022 -13.72%
Dec 31, 2021 -10.48%
Sep 30, 2021 -4.54%
Jun 30, 2021 -7.13%